Verify any claim · lenz.io
Claim analyzed
Science“Lactic acid bacteria present in kimchi can bind to intestinal microplastics and facilitate their excretion from the human body.”
The conclusion
The underlying science is real but overstated. A 2026 peer-reviewed study showed a kimchi-derived bacterium (Leuconostoc mesenteroides CBA3656) can adsorb polystyrene nanoplastics and increase their fecal excretion — in germ-free mice. No human clinical trials have confirmed this effect. The claim's reference to "the human body" implies proven human efficacy that does not yet exist. Additionally, only specific LAB strains were tested against specific plastic types, not the diverse microplastics humans actually encounter.
Caveats
- All direct evidence for LAB binding and excreting microplastics comes from germ-free mouse models and in vitro experiments — no human clinical trials have been conducted.
- The tested effect is specific to particular bacterial strains (e.g., Leuconostoc mesenteroides CBA3656) and primarily polystyrene nanoplastics, not the diverse real-world microplastic mixture humans encounter.
- Researchers have flagged an unresolved safety concern: LAB-microplastic complexes could potentially increase the bioaccessibility of co-pollutants (heavy metals, persistent organic pollutants) sorbed onto the plastics.
Sources
Sources used in the analysis
This study investigated the adsorption capacity of Leuconostoc mesenteroides CBA3656, a lactic acid bacterium isolated from kimchi, against polystyrene nanoplastics (PS-NPs). In animal experiments using a germ-free mouse model, mice administered strain CBA3656 showed more than a twofold increase in nanoplastics detected in feces compared to the control group, suggesting that the probiotic contributes to the excretion of nanoplastics by binding to them in the intestine.
Lactic acid bacteria (LAB), recognized as safe food-grade microorganisms, possess the capability to bioconjugate harmful substances. This study showed that LAB with a high intercalation capacity with MNPs in vitro were more effective in alleviating the toxicity caused by MNPs exposure, and their mitigation of MNPs toxicity extends beyond bio-binding to include repairing the damaged gut environment.
This study identified two probiotic strains, *Lacticaseibacillus paracasei DT66* and *Lactiplantibacillus plantarum DT88*, that exhibited high adsorption capacity on various common microplastics. In an animal model, mice treated with these probiotics demonstrated a 34% increase in polystyrene excretion rates and a 67% reduction in residual polystyrene particles within the intestine, with *Lactiplantibacillus plantarum DT88* also mitigating polystyrene-induced intestinal inflammation.
Teng et al. (2024) screened 784 bacterial strains for their ability to adsorb 0.1 µm polystyrene particles, and identified strains such as Lacticaseibacillus paracasei DT66 and Lactiplantibacillus plantarum DT88 with significant adsorption capabilities in vitro. Similarly, Shi et al. (2025) demonstrated that Lactobacillus plantarum strains with varying antioxidant capacities and affinities for PS-NPs could mitigate the toxicity induced by PS-MPs, and their binding affinity for PS-NPs decreased the body's PS-MPs content by increasing fecal excretion.
MPs can act as carriers for co-pollutants such as persistent organic pollutants (POPs), heavy metals, antibiotics, and pathogens. A critical unresolved issue is whether probiotics that bind to MPs could unintentionally promote the uptake of these sorbed hazardous substances or pathogenic microbes. Although existing evidence highlights the protective role of probiotics, further research is needed to determine if microbe-MP complexes alter the bioaccessibility of toxicants.
Researchers in South Korea found that a bacterium living in fermented kimchi, *Leuconostoc mesenteroides* CBA3656, can help flush out nanoplastics. In experiments with germ-free mice, those given CBA3656 excreted more than double the amount of plastic in their feces compared to the control group, indicating the bacteria bind to the plastic in the gut and escort it out of the body.
The World Institute of Kimchi announced that a lactic acid bacterium isolated from kimchi can help promote the removal of nanoplastics from the body by binding to them in the intestine. A research team investigated the adsorption capacity of *Leuconostoc mesenteroides* CBA3656 against polystyrene nanoplastics (PS-NPs), finding that this kimchi-derived strain can stably bind nanoplastics even in environments resembling the human intestinal tract, maintaining a 57% adsorption rate under simulated human intestinal conditions.
Emerging studies reveal that probiotic supplementation can counteract many adverse effects of microplastics (MPs) in vivo. In mouse models, co-administration of probiotics has been shown to mitigate MP-induced gut inflammation, restore microbiota diversity, and preserve intestinal barrier function. *In vivo* experiments demonstrated that mice treated with these probiotics exhibited a 34% increase in PS excretion rates and a 67% reduction in residual PS particles within the intestine.
Modulation of the gut microbiota through the use of probiotics may be beneficial in protecting against MNPs damages. Researchers suggest probiotics may counteract the toxic effects of MNPs on gut microbiota through several mechanisms, such as reinforcing the intestinal barrier, promoting the production of cytokines, chemokines, and IgA-secreting cells, normalizing microbial communities, producing beneficial fatty acids, modulating anti-inflammatory responses, and potentially influencing the brain-gut axis.
Probiotics, particularly *Lactobacillus* species, can latch onto microplastics via surface proteins, adsorbing them like tiny magnets, which prevents translocation, reduces inflammation, and eases the toxic load. A 2025 study on strains DT66/DT88 (found in fermented foods like kimchi) showed they boosted excretion by 34% and reduced retention by 67% in mice, while also easing inflammation.
Researchers have shown in lab tests and animal studies that certain bacteria, including *Lactiplantibacillus plantarum* and *Lacticaseibacillus paracasei* (found in fermented foods like yogurt and kimchi), may help reduce the plastic load in the gut. The results showed a 34% increase in microplastic excretion in the probiotic group and a 67% reduction in plastic particles remaining in intestinal tissue, along with reduced gut inflammation.
While probiotics in fermented foods may offer some protection by supporting gut health and reducing inflammation, there is no definitive scientific evidence proving they can remove or eliminate microplastics from the body. The claim that fermented foods can detoxify microplastics is considered misleading, and limiting exposure through reduced plastic use and a balanced diet remains the most effective strategy.
Expert review
How each expert evaluated the evidence and arguments
Sources 1–4 (and 6–8) provide a coherent mechanistic chain that certain lactic acid bacteria—including a kimchi-isolated Leuconostoc mesenteroides strain—can adsorb polystyrene nano/microplastics in vitro and, in mouse models, increase fecal recovery of those particles, which supports a capability claim in animals but not a demonstrated effect in humans. Because the claim explicitly says this occurs in the human body, the inference from animal/in vitro evidence to human intestinal microplastics excretion overreaches the evidentiary scope, so the claim is not established as stated.
The claim states that kimchi LAB "can bind to intestinal microplastics and facilitate their excretion from the human body" — the phrase "human body" is the critical framing issue. All direct mechanistic evidence (Sources 1, 3, 8) comes from germ-free mouse models, and Source 2 relies on in vitro bio-binding data; no human clinical trials exist confirming this effect in humans. Source 5 explicitly flags unresolved questions about whether microbe-MP complexes alter bioaccessibility of co-pollutants in humans, and Source 12 (though low-authority and pre-dating 2026 evidence) correctly notes no definitive human evidence exists. The claim also omits that the tested strains are specific isolates (e.g., Leuconostoc mesenteroides CBA3656), not representative of all kimchi LAB, and that the adsorption was tested primarily against polystyrene nanoplastics rather than the diverse real-world microplastic mixture humans encounter. The biological mechanism is well-supported in animal/in vitro models and is plausible for humans, but the claim's framing implies established human efficacy that the evidence does not yet confirm, making it misleading without these caveats.
The highest-authority sources are Source 1 (Bioresource Technology, peer-reviewed, 2026) and Source 2 (PubMed-indexed, 2024), both of which provide direct experimental evidence that kimchi-derived LAB — specifically Leuconostoc mesenteroides CBA3656 — can adsorb microplastics and increase fecal excretion in animal models; Sources 3 and 4 (PMC and AIMS Microbiology) independently corroborate the binding-and-excretion mechanism with different LAB strains, while Source 5 (PMC, 2026) is a credible neutral voice flagging unresolved questions about human applicability and safety of microbe-MP complexes. The claim as worded ("can bind to intestinal microplastics and facilitate their excretion from the human body") is well-supported by reliable peer-reviewed sources for the binding and excretion mechanism, but the evidence base is entirely animal/in vitro — no human clinical data exists — making the phrase "human body" an extrapolation beyond what the authoritative sources have actually demonstrated; Source 12, the sole refuting source, is a low-authority fact-check blog that is scientifically outweighed but correctly identifies the absence of definitive human evidence, and Sources 6, 7, 10, 11 are secondary/popular-press outlets that add no independent verification beyond summarizing Source 1's findings.
Expert summary
What do you think of the claim?
The arguments
Two AI advocates debated this claim using the research gathered.
The claim is directly and powerfully supported by Source 1 (Bioresource Technology), a highly authoritative peer-reviewed study published in 2026, which demonstrated that Leuconostoc mesenteroides CBA3656 — a lactic acid bacterium isolated specifically from kimchi — produced a more than twofold increase in nanoplastics detected in feces of germ-free mice, confirming that this kimchi-derived LAB binds intestinal microplastics and facilitates their excretion. This finding is independently corroborated by Source 3 (PMC), Source 4 (AIMS Microbiology), and Source 8 (KNOWLEDGE_BASE), all of which document LAB strains achieving a 34% increase in polystyrene excretion rates and a 67% reduction in residual intestinal plastic particles in animal models, while the sole dissenting source (Source 12) is a low-authority fact-check blog that predates the most definitive 2026 experimental evidence and cannot override the convergent findings of multiple peer-reviewed studies.
You're smuggling a human conclusion out of non-human evidence: Source 1's “twofold fecal nanoplastics” result is in germ-free mice with polystyrene nanoplastics, not humans with real-world intestinal microplastics, so it cannot “confirm” human excretion—at best it suggests a mechanism worth testing. And your “independent corroboration” is largely circular and overstated because Source 3 is also a mouse model, while Source 4 and Source 8 are reviews summarizing those same animal findings rather than adding human outcome data, which is exactly the gap Source 5 flags as unresolved for microbe–microplastic complexes.
The motion overreaches by asserting a demonstrated effect in humans, yet the only direct “binding → increased fecal excretion” evidence cited comes from animal or in‑vitro work (e.g., germ‑free mice in Bioresource Technology, Source 1; mouse models in PMC, Source 3; and in‑vitro intercalation/bio-binding in PubMed, Source 2), which cannot establish that kimchi LAB bind intestinal microplastics and facilitate human excretion. Even the human-focused review notes key unresolved safety/behavior questions about microbe–microplastic complexes and calls for further research (PMC, Source 5), while a dedicated fact-check explicitly concludes there is no definitive scientific evidence that fermented-food probiotics remove or eliminate microplastics from the body (KNOWLEDGE_BASE, Source 12).
Your argument commits a classic moving-the-goalposts fallacy: the claim states that kimchi LAB "can bind to intestinal microplastics and facilitate their excretion," which is precisely what Source 1 (Bioresource Technology, 2026) demonstrates mechanistically — a kimchi-isolated strain maintaining 57% adsorption under simulated human intestinal conditions (Source 7) and producing a twofold fecal excretion increase in vivo — and demanding human clinical trials as the only acceptable standard of proof ignores that animal and in vitro models are the established scientific foundation for demonstrating biological capability, not a disqualifying limitation. Your reliance on Source 12 is particularly weak: it is a low-authority fact-check blog published in January 2025 that explicitly predates the most definitive 2026 peer-reviewed experimental evidence from Source 1, making it scientifically obsolete and wholly insufficient to override the convergent mechanistic findings of Sources 1, 2, 3, and 4.